178 related articles for article (PubMed ID: 16961137)
41. The rs243866/243865 polymorphisms in MMP-2 gene and the relationship with BP control in obese resistant hypertensive subjects.
Ritter AMV; de Faria AP; Barbaro NR; Sabbatini AR; Corrêa NB; Brunelli V; Fattori A; Amorim R; Modolo R; Moreno H
Gene; 2018 Mar; 646():129-135. PubMed ID: 29288728
[TBL] [Abstract][Full Text] [Related]
42. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
43. The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture.
Khurana VG; Meissner I; Sohni YR; Bamlet WR; McClelland RL; Cunningham JM; Meyer FB
J Neurosurg; 2005 Mar; 102(3):526-31. PubMed ID: 15796389
[TBL] [Abstract][Full Text] [Related]
44. Association of polymorphisms in the elastin gene with sporadic ruptured intracranial aneurysms and unruptured intracranial aneurysms in Chinese patients.
Yang S; Wang T; You C; Liu W; Zhao K; Sun H; Mao B; Li X; Xiao A; Mao X; Zhang H
Int J Neurosci; 2013 Jul; 123(7):454-8. PubMed ID: 23294012
[TBL] [Abstract][Full Text] [Related]
45. MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.
Korkmaz KS; de Rooij BJ; van Hoek B; Janse M; Coenraad MJ; van der Reijden JJ; Weersma RK; Porte RJ; Voorneveld PW; Baranski AG; Verspaget HW
Liver Int; 2014 Feb; 34(2):274-80. PubMed ID: 23809662
[TBL] [Abstract][Full Text] [Related]
46. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
47. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
48. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis].
Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A
Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991
[TBL] [Abstract][Full Text] [Related]
49. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Duarte G; Tanus-Santos JE
Exp Mol Pathol; 2012 Apr; 92(2):217-21. PubMed ID: 22327101
[TBL] [Abstract][Full Text] [Related]
50. Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms.
Marchese E; Vignati A; Albanese A; Nucci CG; Sabatino G; Tirpakova B; Lofrese G; Zelano G; Maira G
J Biol Regul Homeost Agents; 2010; 24(2):185-95. PubMed ID: 20487632
[TBL] [Abstract][Full Text] [Related]
51. Interleukin 6 gene polymorphisms are not associated with aneurysmal subarachnoid haemorrhage in an Italian population.
Fontanella M; Rainero I; Gallone S; Rubino E; Fenoglio P; Valfrè W; Garbossa D; Benevello C; Ducati A; Pinessi L
J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):471-3. PubMed ID: 18344399
[TBL] [Abstract][Full Text] [Related]
52. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Singh M; Singh M
Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210
[TBL] [Abstract][Full Text] [Related]
53. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
[TBL] [Abstract][Full Text] [Related]
54. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
55. Genetics of intracranial aneurysms.
Ruigrok YM; Rinkel GJ; Wijmenga C
Lancet Neurol; 2005 Mar; 4(3):179-89. PubMed ID: 15721828
[TBL] [Abstract][Full Text] [Related]
56. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
[TBL] [Abstract][Full Text] [Related]
57. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm.
Peters DG; Kassam A; St Jean PL; Yonas H; Ferrell RE
Stroke; 1999 Dec; 30(12):2612-6. PubMed ID: 10582986
[TBL] [Abstract][Full Text] [Related]
58. Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms.
Caird J; Napoli C; Taggart C; Farrell M; Bouchier-Hayes D
Eur J Neurol; 2006 Oct; 13(10):1098-105. PubMed ID: 16987162
[TBL] [Abstract][Full Text] [Related]
59. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
60. Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms.
Krex D; Ziegler A; König IR; Schackert HK; Schackert G
Cerebrovasc Dis; 2003; 16(4):363-8. PubMed ID: 13130177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
